Pancreatic Cancer Research

ResearcherUniversity of GroningenActive in the last 2 years

Gert N. Moll

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0001-5762-5667; OpenAlex author ID A5046965723.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
1
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer. First author DOI 10.1016/j.ejphar.2024.176772↗
  2. Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/ijms241210193↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Pawel Namsolleck · 1 shared paper, 2023

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.